Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
- PMID: 35975242
- PMCID: PMC9373931
- DOI: 10.1093/gastro/goac032
Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
Figures
References
-
- Ordás I, Eckmann L, Talamini M. et al. Ulcerative colitis. Lancet 2012;380:1606–19. - PubMed
-
- Puzik A, Thiel A, Faust K. et al. Thalidomide has anti-inflammatory properties in neonatal immune cells. Innate Immun 2013;19:42–52. - PubMed
-
- Turner D, Ruemmele FM, Orlanski-Meyer E. et al. Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257–91. - PubMed
LinkOut - more resources
Full Text Sources
